Sopharma AD (BUL:SFA) signed an agreement to acquire Pharmanova d.o.o on July 14, 2023. Sopharma will initially acquire an interest of 25% in Pharmanova, then purchase another 50% ownership in a year's time, with the remaining 25% to be bought within two years. As of FY 2022, Pharmanova generated net sales revenue of over ?10.2 million.

The transaction is subject to approval by the Serbian competition authority and is expected to complete within 2 years. As on November 10, 2023, Sopharma AD acquired 25% of the capital of Pharmanova d.o.o. Sa?a Stojanovic, Dorde Vicic, Anja Tasic and ?ivko Kovacevic. from Radovanovic Stojanovic & Partners acted as legal advisors to Pharmanova d.o.o shareholders.

Djordje Nikolic, Branko Jankovic and Djuro Otasevic from NKO Partners acted as legal advisors to Sopharma AD (BUL:SFA).